The use of prostate specific antigen for prostate cancer screening: A managed care perspective

Journal of Urology

Volumn 152, Issue 5 II, 1994, Pages 1689-1692

  Handley, M R ^a   Stuart, M E ^a  

^a CENTER FOR HEALTH STUDIES   (United States)

Author keywords

antigens, neoplasm; decision making; diagnostic tests, routine; preventive medicine; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; CONFERENCE PAPER; COST CONTROL; DIAGNOSTIC TEST; HEALTH CARE COST; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MALE; MEDICAL DECISION MAKING; PATIENT CARE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; SCREENING TEST;

EID: 0027940605     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(17)32362-5     Document Type: Conference Paper

References (18)

1. G.L. Lu-Yao D. McLerran J.H. Wasson J.E. Wennberg An assessment of radical prostatectomy: time trends, geographic variation, and outcomes J.A.M.A. 269 1993 2633
2. W.J. Catalona D.S. Smith T.L. Ratliff K.M. Dobbs D.E. Coplen J.J.J. Yuan Measurement of prostate specific antigen in serum as a screening test for prostate cancer New Engl. J. Med. 324 1991 1156
3. R. Scott D.L. Mutchnik T.Z. Laskowski W.R. Schmalhorst Carcinoma of the prostate in elderly men: incidence, growth characteristics, and clinical significance J. Urol. 101 1969 602
4. L.M. Franks Etiology epidemiology of human prostatic disorders. Urologic pathology M. Tannenbaum The Prostate 1977 Lea & Febiger Philadelphia
5. F. Hinman Jr. Screening for prostatic carcinoma J. Urol. 145 1991 126
6. M.K. Brawer M.P. Chetner J. Beatie D.M. Buchner R.L. Vessella P.H. Lange Screening for prostatic carcinoma with prostate specific antigen J. Urol. 147 1992 841
7. J.E. Oesterling Prostate-specific antigen: improving its ability to diagnose early prostate cancer J.A.M.A. 267 1992 2236
8. A.T. Cockett Letter to the editor J.A.M.A. 270 1993 1692
9. M.C. Benson I.S. Whang C.A. Olsson D.J. McMahon W.H. Cooner The use of prostate-specific antigen density to enhance the predictive value of intermediate levels of serum prostate-specific antigen J. Urol. 147 1992 817
10. J.E. Oesterling S.J. Jacobsen C.G. Chute H.A. Guess C.J. Girman L.A. Panser M.M. Lieber Serum prostate-specific antigen in a community-based population of healthy men J.A.M.A. 270 1993 860
11. H.B. Carter J.D. Pearson E.J. Metter L.J. Brant D.W. Chan R. Andres J.L. Fozard P.C. Walsh Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease J.A.M.A. 267 1992 2215
12. B.S. Kramer M.L. Brown P.C. Prorok A.L. Potosky J.K. Gohagan Prostate cancer screening: what we know and what we need to know Ann. Intern. Med. 119 1993 914
13. J.E. Johansson H.O. Adami S.O. Andersson R. Bergström L. Holmberg U.B. Krusemo High 10-year survival rate in patients with early, untreated prostatic cancer J.A.M.A. 267 1992 2191
14. G.W. Chodak R.A. Thisted G.S. Gerber J.E. Johansson J. Adolfsson G.W. Jones G.D. Chisolm B. Moskovitz P.M. Livne J. Warner Results of conservative management of clinically localized prostate cancer New Engl. J. Med. 330 1994 242
15. J.H. Wasson C.C. Cushman R.C. Bruskewitz B. Littenberg A.G. Mulley J.E. Wennberg A structured literature review of treatment for localized prostate cancer Arch. Fam. Med. 2 1993 487
16. C. Fleming J.H. Wasson P.C. Albertsen M.J. Barry J.E. Wennberg A decision analysis of alternative treatment strategies for clinically localized prostate cancer J.A.M.A. 269 1993 2650
17. S.A. Optenberg I.M. Thompson Economics of screening for carcinoma of the prostate Urol. Clin. N. Amer. 17 1990 719
18. M.E. Stuart M.R. Handley R.S. Thompson M. Conger D. Timlin Clinical practice and new technology: prostate specific antigen HMO Pract. 6 1992 5